Palouse Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-400
Closed -$21.7K 122
2024
Q1
$21.7K Buy
+400
New +$20.4K 0.01% 125
2022
Q1
Sell
-90,553
Closed -$5.65M 102
2021
Q4
$5.65M Sell
90,553
-5,432
-6% -$319K 2.41% 10
2021
Q3
$5.68M Sell
95,985
-2,432
-2% -$160K 2.52% 13
2021
Q2
$6.58M Sell
98,417
-399
-0.4% -$26K 2.87% 4
2021
Q1
$6.24M Buy
98,816
+33,847
+52% +$2.11M 2.75% 5
2020
Q4
$4.03M Sell
64,969
-7,109
-10% -$437K 2.13% 14
2020
Q3
$4.35M Sell
72,078
-15,531
-18% -$935K 2.43% 13
2020
Q2
$5.15M Sell
87,609
-3,262
-4% -$195K 2.72% 7
2020
Q1
$5.07M Sell
90,871
-3,708
-4% -$227K 2.99% 6
2019
Q4
$6.07M Sell
94,579
-5,984
-6% -$343K 2.3% 14
2019
Q3
$5.1M Buy
+100,563
New +$4.73M 1.89% 23

Other funds holding BMY